HMPL-342

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHMPL-342
Drug Alias NameI-kappa beta kinase inhibitor (Hutchison Medipharma)HM-A42HMPL-342
ClassificationSmall molecules
Mechanisms of ActionInhibitor of nuclear factor kappa-B kinase subunit beta inhibitors
TargetsInhibitor of nuclear factor kappa-B kinase subunit beta
Therapy Area/IndicationsAutoimmune DiseasesPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHutchison Medipharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHutchison Medipharma Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A